June 30, 2020 / 11:40 AM / 10 days ago

Inovio's COVID-19 vaccine candidate shows promise in early-stage trial

June 30 (Reuters) - Inovio Pharmaceuticals Inc on Tuesday reported positive interim data from an early-stage study assessing its potential COVID-19 vaccine wherein patients showed immune response and was deemed safe. (reut.rs/2NFcNqL) (Reporting by Trisha Roy in Bengaluru; Editing by Arun Koyyur)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below